Antibody Therapeutics for Life

Notices

Dr. Jin-San Yoo, CEO of PharmAbcine is presenting PharmAbcine`s R&D progress and the interim data of the ongoing phase IIa recurrent GBM trial at 2017 Bio International Convention in San Diego on June 19-22, 2017.
  • Written by Admin
  • Written date 2019-01-14 11:26:40
  • Inquire 1845

Dr. Jin-San Yoo, CEO of PharmAbcine is presenting PharmAbcine`s R&D progress and the interim data of the ongoing phase IIa recurrent GBM trial

at 2017 Bio International Convention in San Diego on June 19-22, 2017.

 

http://convention.bio.org/

List





Prev Dr. Lawrence Cher, principle investigator of Tanibirumab phase IIa recurrent GBM...
Next Dr. Jin-San Yoo, CEO of PharmAbcine is presenting at the forum for future pharm ...